LobbyingEagle Pharmaceuticals lobbying by quarter
Eagle Pharmaceuticals's latest lobbying report covers Q4 2024, at $30K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Eagle Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $30K | 1 |
| Q1 2023 | $30K | 1 |
| Q2 2023 | $30K | 1 |
| Q3 2023 | $30K | 1 |
| Q4 2023 | $30K | 1 |
| Q1 2024 | $30K | 1 |
| Q2 2024 | $30K | 1 |
| Q3 2024 | $30K | 1 |
| Q4 2024 | $30K | 1 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$135K · 9 reports
- Medicare and Medicaid$135K · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES9 reports
- SENATE9 reports
Firms it paid
| Firm | ||
|---|---|---|
| Jeffrey J. Kimbell & Associates | $270K | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JOHN HERZOG | Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President | Q4 2024 |
| JOHN R RAY | Legislative Assistant, Rep. Mike Kelly | Q4 2024 |
| KEITH STUDDARD | Legislative Director, Rep. Marsha Blackburn | Q4 2024 |
| KELSEY CARLSON | Special Assistant, National Security Council; Special Assistant, International Trade Administration, Dept of Commerce; Policy Advisor, Office of the Deputy Chief of Staff, Executive Office of the President; Confidential Assistant, Dept of Commerce | Q4 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/01/09for Q4 2024 | Jeffrey J. Kimbell & Associates | $30K |
| 24/10/17for Q3 2024 | Jeffrey J. Kimbell & Associates | $30K |
| 24/07/15for Q2 2024 | Jeffrey J. Kimbell & Associates | $30K |
| 24/04/17for Q1 2024 | Jeffrey J. Kimbell & Associates | $30K |
| 24/01/18for Q4 2023 | Jeffrey J. Kimbell & Associates | $30K |
| 23/10/20for Q3 2023 | Jeffrey J. Kimbell & Associates | $30K |
| 23/07/20for Q2 2023 | Jeffrey J. Kimbell & Associates | $30K |
| 23/04/17for Q1 2023 | Jeffrey J. Kimbell & Associates | $30K |
| 23/01/18for Q4 2022 | Jeffrey J. Kimbell & Associates | $30K |